[2-ETHYLAMINO-3-  PHENYLNOCAMPHANE HYDROCHLORIDE (H-610) IN INTRAVENOUS ADMINISTRATION IN THE TREATMENT OF MENTAL DISEASES: CLINICAL STUDY OF 38 PATIENTS].
D061605:Administration, Intravenous; D000697:Central Nervous System Stimulants; D006801:Humans; D001523:Mental Disorders; D011618:Psychotic Disorders
D000697:Central Nervous System Stimulants
ANALEPTICS; MENTAL DISORDERS